https://www.sec.gov/Archives/edgar/data/1205059/000106299321000815/exhibit99-3.htm
RepliCel Life Sciences Inc.: Exhibit 99.3 - Filed by newsfilecorp.com
life sciences99 3replicelincexhibit
https://www.fiercebiotech.com/biotech/replicel-says-hair-loss-therapy-safe-glimmers-efficacy
Replicel says hair loss therapy is safe, with glimmers of efficacy | Fierce Biotech
Mar 14, 2017 - A cell-based therapy for pattern baldness has passed its first phase 1 safety test.
hair loss therapy
https://investingnews.com/daily/life-science-investing/medical-device-investing/replicel-ceo-anticipating-approval-dermal-injector-impact-europe-beyond/
RepliCel CEO: Anticipating the Approval of Their Dermal Injector, its Impact in Europe and Beyond |...
Jan 5, 2026 - Lee Buckler, president, director and CEO of RepliCel Life Sciences (TSXV:RP; OTCQB:REPCF) finds his company in a very particular situation. Throughout 2017...
https://www.fiercebiotech.com/keyword/replicel-life-sciences
Replicel Life Sciences | Fierce Biotech
life sciencesreplicelfiercebiotech
https://www.newswire.ca/news-releases/replicel-collaborates-with-university-of-british-columbia-to-build-world-class-hair-follicle-cell-data-map-628130693.html
RepliCel Collaborates with University of British Columbia to Build World-Class Hair Follicle Cell...
/CNW/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) ("RepliCel" or the "Company") is pleased to announce it has signed a collaborative...